F5 NUNATURALS CORP. – Trademark Portfolio
Entity Type: 03
F5 NUNATURALS CORP. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include KH-9, LICEX, SCODS, VINTIMÉ, and APETIMAX. The owner is based in MIAMI, FL.
7400 NW 7TH STREET,UNIT 109
MIAMI, FL 33126
Showing of trademarks Trademarks
Trademark Classifications
F5 NUNATURALS CORP.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does F5 NUNATURALS CORP. have?
F5 NUNATURALS CORP. has 18 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 abandoned, 7 cancelled.
What trademark classes does F5 NUNATURALS CORP. file in?
F5 NUNATURALS CORP. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are F5 NUNATURALS CORP.'s most well-known trademarks?
F5 NUNATURALS CORP.'s registered trademark portfolio includes well-known marks such as KH-9, LICEX, SCODS, VINTIMÉ, and APETIMAX. These are among 10 currently registered trademarks in the portfolio.
What is F5 NUNATURALS CORP.'s trademark registration success rate?
F5 NUNATURALS CORP. has a 56% trademark registration rate, with 10 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.